Identification of Mycobacterium abscessus complex and M. abscessus subsp. massiliense culture isolates by real-time assays
Recent worldwide increases in the incidence of Mycobacterium abscessus complex (MABSC) infection are of concern given it is recognized as the most pathogenic of the rapidly growing Mycobacterium species (Benwill & Wallace, 2014) . MABSC is typically associated with soft-tissue and skin infections, but can also cause potentially fatal pulmonary disease in immunocompromised patients and those with chronic pulmonary disease, including in patients with cystic fibrosis (Harris & Kenna, 2014) . Recent taxonomic descriptions based on whole-genome sequencing studies have shown that MABSC comprises three subspecies: M. abscessus subsp. abscessus, M. abscessus subsp. bolletii and M. abscessus subsp. massiliense (Bryant et al., 2013) . Correct identification of MABSC species and subspecies is imperative due to their differing antibiotic treatment regimens (Griffith et al., 2007) . Of note, M. abscessus subsp. massiliense is generally more susceptible to current treatments than M. abscessus subsp. abscessus and M. abscessus subsp. bolletii (Roux et al., 2014) , particularly as it has a truncated erm41 gene, being a non-functional form of an erythromycin ribosomal methylase gene sequence (Kim et al., 2010) . Therefore, rapid and specific identification of M. abscessus subsp. massiliense can be useful to inform treatment. It is in this context that M. abscessus subsp. massiliense has garnered a new level of importance in cystic fibrosis microbiology, given recent reports of crossinfection between patients with cystic fibrosis in the UK and USA (Aitken et al., 2012; Tettelin et al., 2014) , as well as increased rates of MABSC infection in our own local cystic fibrosis clinics in Queensland, Australia (unpublished data).
Species and subspecies identification of MABSC can be problematic. For example, many reference laboratories, including our own, employ commercial molecular lineprobe assays such as the Hain Life Sciences GenoType Mycobacterium CM kit for the identification of common pathogenic mycobacteria isolates (Harris & Kenna, 2014) . Whilst offering broad-based Mycobacterium species discrimination in a multiplex format, the test takes ,8 h to perform. In addition, there have been reported issues for MABSC species-level identification with misidentification of MABSC as Mycobacterium chelonae (Lee et al., 2009) , as well as an inability to discriminate the three MABSC subspecies (Tortoli et al., 2010) . DNA sequencingbased approaches using multiple gene targets are now generally regarded as the most accurate means of identifying MABSC species and subspecies (Blauwendraat et al. 2012; Zelazny et al., 2009) ; however, such approaches are typically too time-consuming, slow and expensive for routine diagnostic use.
To address the above issues, we designed two real-time PCR TaqMan assays to facilitate a simplified and more rapid species-specific detection of MABSC isolates, as well as subspecies discrimination of M. abscessus subsp. massiliense. The MABSC real-time TaqMan assay (MABSCrtPCR) was designed to target a 172 bp sequence within the 'Telenti' fragment of the hsp65 gene, being a commonly used target for Mycobacterium species identification by DNA sequencing-based methods (Zelazny et al., 2009) . For M. abscessus subsp. massiliense identification, a realtime TaqMan assay (Mam-rtPCR) was developed targeting a 183 bp sequence of the truncated erm41 gene that is typically possessed by this MABSC subspecies only (Kim et al., 2010; Shallom et al., 2013) . In brief, multiple sequences for both targets were downloaded from GenBank and aligned using BioEdit version 7.2.5 to identify suitable primer and probe targets. In total, 102 Mycobacterium isolates were included in the study, including M. abscessus subsp. abscessus ATCC 19777 as a reference strain and 101 confirmed (n533) or presumptive (n568) Mycobacterium species isolates from local patients. For the MABSC-rtPCR and Mam-rtPCR testing of the isolates, a crude boil-up method was used to extract DNA. Briefly, isolates were grown on solid medium (Lowenstein-Jensen media+pyruvate) at 35 8C until abundant growth was detected. A 10 ml loopful of bacteria was treated with 300 ml 100 % ethanol in a microcentrifuge tube containing glass beads for 30 min at room temperature and then centrifuged at 10 000 r.p.m. for 10 min. After the ethanol was decanted, cells were resuspended in 300 ml sterile water and inactivated at 95 8C for 30 min. After centrifugation at 10 000 r.p.m. for 10 min, the supernatant was then ready for PCR. Each 50 ml PCR contained 25 ml 26 ABI Universal PCR Mix (Life Technologies), 0.9 mM primers, 0.25 mM MGB probe and 5 ml crude DNA extract or sterile water as a negative control. The assays were performed on an Applied Biosystems ViiA 7 Real-Time PCR System (Life Technologies) using the following cycling conditions: an initial denaturation at 95 8C for 10 min followed by 45 cycles of a two-step cycle: 95 8C for 15 s and 60 8C for 1 min. Positive and two negative controls were tested in each run. To evaluate the performance of the MABSC-rtPCR and Mam-rtPCR assays, the 102 isolates were also tested by a conventional PCR targeting the erm41 gene (erm41-PCR), and were subjected to hsp65, rpoB and secA1 DNA sequencing as described previously (Zelazny et al., 2009) ; Hain line-probe assays results were available for a subset of isolates (n533) from previous routine clinical testing. The conventional erm41-PCR uses agarose gel electrophoresis-based detection for specific detection of MABSC and simultaneously distinguishes M. abscessus subsp. massiliense on the basis of PCR product size (397 bp as compared with 673 bp for M. abscessus subspp. abscessus and bolletii). (Kim et al. 2010) . A consensus reference standard approach was used, whereby species identification was based on agreement between the results of two or more of the erm41-PCR, hsp65, rpoB and secA1 sequencing, and Hain line-probe methods (Table 1) . Based on this reference standard, 72 isolates were determined to be MABSC species (M. abscessus subsp. abscessus, n542; M. abscessus subsp. bolletii, n57; M. abscessus subsp. massiliense, n523) and the remaining 30 isolates comprised a range of non-MABSC species, including M. chelonae (n53), Mycobacterium tuberculosis complex (n52), Mycobacterium avium (n53), Mycobacterium intracellulare (n51), Mycobacterium fortuitum (n53), Mycobacterium kansasii (n52), Mycobacterium haemophilum (n52), and other Mycobacterium (n511) and nonMycobacterium species (n53).
Both the MABSC-rtPCR and Mam-rtPCR assays provided good agreement with the results obtained by the reference standard (Table 1) . In summary, all 72 MABSC isolates were correctly identified by the MABSC-rtPCR (C t 514.1-24.2 cycles), as were all M. abscessus subsp. massiliense isolates by the Mam-rtPCR (C t 519.7-25.8 cycles). There was, however, one isolate that gave a positive result in the MABSC-rtPCR, but was identified as a Gordonia species by DNA sequencing. We initially thought that this may have been due to the isolate comprising a mixture of species, as during the early phases of the study we had observed six other non-MABSC isolates that initially provided delayed signals (n55 isolates; C t 531.7-42.1 cycles) in MABSC-rtPCR or Mam-rtPCR assays, but were subsequently negative by these assays following subculturing of the isolates to ensure purity (data not shown). However, subculturing did not resolve the result for this Gordonia isolate. Despite this, we do not see this as a limitation of the method for identification of MABSC isolates given that this false-positive result could otherwise be distinguished on the basis of the late C t value (42.4 cycles), being .10 cycles later than those observed for the MABSC isolates. To this effect, we will now seek to standardize isolate DNA concentrations and establish cycles value cut-offs for these methods. Of further interest was that three of the 33 Hain lineprobe results provided discordant results; two isolates that were identified as M. abscessus subsp. massiliense isolates by all other methods were called M. chelonae by the line-probe assay, whereas one isolate identified as Mycobacterium triplex by DNA sequencing was called M. avium. These results are consistent with recognized specificity problems of this technology (Lee et al., 2009) . It should, however, be noted that the evaluations of the MABSC-rtPCR and Mam-rtPCR assays were limited to local isolates, and, unlike the Hain line-probe assay, the methods have not been validated against a broader range of Mycobacterium species or isolates from different geographical locations. Thus, further evaluation may be warranted before routine use in other settings.
In conclusion, these preliminary data indicate the MABSC-rtPCR and MamrtPCR assays are useful tools to aid in the identification of MABSC and M. massiliense isolates, respectively. We are currently investigating the application of these assays directly on clinical specimens as a more rapid means of diagnosis of MABSC infections, which we believe will be an important next step in identifying MABSC infections in persons with cystic fibrosis. Such utility may also assist clinicians where mixed non-tuberculous mycobacterial infection can prevent the laboratory readily reporting species identification and drug susceptibility testing by traditional phenotypic methods.
